About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
559 genotypes with 927 annotations displayed of selected term and subterms
Searched Term: abnormal hemostasis
Allelic Composition
(Genetic Background)		 Annotated Term Reference
a/a
Hps6ru/Hps6ru
(B6.Cg-Hps6ru) 		increased bleeding time J:7327
a/a
Rab27aash/Rab27aash
(involves: C3H/HeSnJ * C57BL/6J) 		increased bleeding time J:77395
Abca1tm1Blt/Abca1tm1Blt
(C57BL/6-Abca1tm1Blt) 		abnormal platelet physiology J:95088
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj) 		abnormal cardiac thrombosis J:99152
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR) 		abnormal cardiac thrombosis J:99152
Abcg5trac/Abcg5trac
(A/J-Abcg5trac) 		abnormal platelet activation J:157223
decreased platelet aggregation J:157223
increased bleeding time J:157223
Achetm1.1Pata/Achetm1.1Pata
(involves: 129X1/SvJ * C57BL/6) 		abnormal platelet physiology J:132775
Ackr3tm1Jgo/Ackr3tm1Jgo
(involves: 129S/SvEvBrd * C57BL/6) 		abnormal atrial thrombosis J:136246
Actc1tm1Jll/Actc1tm1Jll
Tg(Myh6-Actg2)1Jll/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N) 		abnormal cardiac thrombosis J:40165
Adam10tm1Beni/Adam10tm1Beni
Adam17tm1.1Srj/Adam17tm1.1Srj
Tg(Pf4-icre)Q3Rsko/0
(involves: 129/Sv * 129S/SvEv * C57BL/6) 		abnormal platelet physiology J:165863
Adam10tm1Beni/Adam10tm1Beni
Tg(Pf4-icre)Q3Rsko/0
(involves: 129/Sv * C57BL/6) 		abnormal platelet physiology J:165863
Adam17tm1.1Srj/Adam17tm1.1Srj
(involves: 129S/SvEv) 		abnormal platelet physiology J:165863
Adamts13s/Adamts13s
(129.B6-Adamts13s) 		increased susceptibility to induced thrombosis J:148975
Adamts13tm1Dgi/Adamts13tm1Dgi
(involves: 129X1/SvJ * C57BL/6J * CASA/Rk) 		abnormal platelet physiology J:101752
abnormal thrombosis J:101752
Adamts13tm1Dgi/Adamts13tm1Dgi
(B6.129X1-Adamts13tm1Dgi) 		increased susceptibility to induced thrombosis J:133469
Adamts13tm1Dgi/Adamts13tm1Dgi
Vwftm1Wgr/Vwftm1Wgr
(B6.129-Adamts13tm1Dgi Vwftm1Wgr) 		decreased susceptibility to induced thrombosis J:133469
Adamts13tm1Myta/Adamts13tm1Myta
(involves: 129S6/SvEvTac) 		abnormal blood coagulation J:125786
abnormal platelet activation J:125786
abnormal thrombosis J:125786
Adora2atm1Map/Adora2atm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased platelet aggregation J:42276
Adtrptm1.1Clu/Adtrptm1.1Clu
(involves: 129S4/SvJaeSor * C57BL/6) 		increased bleeding time J:295059
Agbl4Tn(pb-Act-RFP)1.080115015-HRAZhu/Agbl4Tn(pb-Act-RFP)1.080115015-HRAZhu
(involves: FVB/N) 		abnormal hemostasis J:233744
abnormal platelet physiology J:233744
decreased platelet aggregation J:233744
increased bleeding time J:233744
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N) 		abnormal atrial thrombosis J:44690
abnormal thrombosis J:44690
Akip1em1Cya/Akip1em1Cya
(C57BL/6N-Akip1em1Cya) 		decreased bleeding time J:326919
decreased prothrombin time J:326919
Alox12tm1Fun/Alox12tm1Fun
(involves: 129S2/SvPas * C57BL/6) 		increased platelet aggregation J:46896
increased susceptibility to induced thrombosis J:46896
Ank1nb/Ank1nb
((WB.Cg-Ank1nb/BrkJ x B6.Cg-Ank1nb/BrkJ)F1) 		abnormal cardiac thrombosis J:62355
Ano6tm1.2Lyj/Ano6tm1.2Lyj
(involves: 129X1/SvJ * C57BL/6) 		abnormal platelet physiology J:188263
decreased susceptibility to induced thrombosis J:188263
increased bleeding time J:188263
Ano6tm1Avor/Ano6tm1Avor
(involves: 129) 		increased bleeding time J:260534
anx/anx
Tyro3m1/Tyro3m1
(involves: C3HeB/FeJLe * C57BL/6J) 		abnormal platelet activation J:241666
Anxa2tm1Kah/Anxa2tm1Kah
(involves: 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:87621
increased susceptibility to induced thrombosis J:87621
Anxa7tm1Ngl/Anxa7tm1Ngl
(involves: 129S2/SvPas) 		abnormal platelet aggregation J:91188
Ap3b1pe-rim2/Ap3b1pe-rim2
(involves: B10.A(R201) * C57BL/10Slc) 		abnormal platelet dense granule physiology J:42685
decreased platelet aggregation J:42685
Ap3b1pe/Ap3b1pe
(involves: C3H/He) 		abnormal blood coagulation J:7327
abnormal platelet dense granule physiology J:7327
increased bleeding time J:7327
Ap3b1pe/Ap3b1pe
(B6.C3-Ap3b1pe/J) 		abnormal platelet activation J:221384
decreased platelet aggregation J:221384
increased bleeding time J:7327
Ap3b1tm1Sms/Ap3b1tm1Sms
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased bleeding time J:66256
Ap3d1mh/Ap3d1mh
(STOCK Mfsd12gr +/+ Ap3d1mh/J) 		decreased platelet aggregation J:29151
increased bleeding time J:29151
Ap3d1mh/Ap3d1mh
(B6.C3-Grxcr1pi) 		increased bleeding time J:88018
Apobec1tm1Ddsn/Apobec1tm1Ddsn
Fggtm1Fjc/Fggtm1Fjc
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Fggtm1Fjc Apobec1tm1Ddsn Ldlrtm1Her) 		abnormal blood coagulation J:132734
Apobec1tm1Ddsn/Apobec1tm1Ddsn
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Apobec1tm1Ddsn Ldlrtm1Her) 		abnormal blood coagulation J:132734
decreased partial thromboplastin time J:132734
decreased prothrombin time J:132734
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		abnormal glomerular capillary thrombosis J:125978
Apoetm1Unc/Apoetm1Unc
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal arterial thrombosis J:105858
abnormal blood coagulation J:105858
Apoetm1Unc/Apoetm1Unc
Ldlrtm1Her/Ldlrtm1Her
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		abnormal thrombosis J:95598
Apoetm1Unc/Apoetm1Unc
Lpltm1Sem/Lpltm1Sem
(involves: 129P2/OlaHsd) 		increased susceptibility to induced thrombosis J:151434
Apptm1.1Wevn/Apptm1.1Wevn
(B6.129S6(FVB)-Apptm1.1Wevn) 		increased susceptibility to induced thrombosis J:241632
Apptm1Dbo/Apptm1Dbo
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased susceptibility to induced thrombosis J:241632
Arhgef3tm1(KOMP)Wtsi/Arhgef3tm1(KOMP)Wtsi
(C57BL/6N-Arhgef3tm1(KOMP)Wtsi/DkrsJ) 		abnormal platelet physiology J:241286
Asgr1tm1Sau/Asgr1tm1Sau
(B6.129S4-Asgr1tm1Sau) 		decreased bleeding time J:136946
Asgr2tm1Her/Asgr2tm1Her
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(B6.129-St3gal4tm1.1Jxm Asgr2tm1Her) 		abnormal blood coagulation J:136946
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal brain thrombosis J:70420
abnormal thrombosis J:70420
Babam1Gt(IST11207B9)Tigm/Babam1Gt(IST11207B9)Tigm
(involves: C57BL/6N) 		abnormal platelet physiology J:223526
Bak1tm1Thsn/Bak1tm1Thsn
(B6.129-Bak1tm1Thsn) 		abnormal platelet physiology J:149205
Bak1tm1Thsn/Bak1tm1Thsn
Bcl2l1tm1Dlo/Bcl2l1+
(B6.Cg-Bcl2l1tm1Dlo Bak1tm1Thsn) 		abnormal platelet physiology J:149205
Bap1tm1.1Geno/Bap1tm1.1Geno
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		abnormal cardiac thrombosis J:187380
Bcl2l1Plt16/Bcl2l1+
(involves: BALB/c * C57BL/6) 		abnormal platelet physiology J:149205
Bcl2l1Plt20/Bcl2l1+
(involves: BALB/c * C57BL/6) 		abnormal platelet physiology J:149205
Bcl2l1Plt20/Bcl2l1Plt20
(involves: BALB/c * C57BL/6) 		abnormal platelet physiology J:149205
Bcl2l1tm1Dlo/Bcl2l1+
(B6.Cg-Bcl2l1tm1Dlo) 		abnormal platelet physiology J:149205
Bin2tm1.1Beni/Bin2tm1.1Beni
Tg(Pf4-icre)Q3Rsko/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		abnormal platelet activation J:302510
abnormal platelet physiology J:302510
decreased platelet aggregation J:302510
decreased susceptibility to induced thrombosis J:302510
increased bleeding time J:302510
Bloc1s4cno/Bloc1s4cno
(C3H/HeJ-Bloc1s4cno) 		abnormal platelet dense granule physiology J:61187
decreased platelet aggregation J:61187
increased bleeding time J:61187
Bloc1s5mu/Bloc1s5mu
(involves: STOCK t) 		abnormal platelet physiology J:29151
decreased platelet aggregation J:29151
increased bleeding time J:29151
Bloc1s5mu/Bloc1s5mu
(CHMU/Le) 		abnormal platelet dense granule physiology J:29151
decreased platelet aggregation J:29151
increased bleeding time J:29151
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J) 		abnormal platelet activation J:7327, J:221384
abnormal platelet physiology J:221384
decreased platelet aggregation J:221384
increased bleeding time J:7327
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra) 		abnormal venous thrombosis J:191844
decreased prothrombin time J:191844
hypercoagulability J:191844
increased partial thromboplastin time J:191844
increased susceptibility to induced thrombosis J:191844
Bmpr2tm1.1Enl/Bmpr2tm1.1Enl
Tg(Acvrl1-cre)L1Spo/0
(involves: 129S4/SvJae * FVB) 		abnormal lung thrombosis J:158116
Btctm1Dcl/Btctm1Dcl
Hbegftm1Dcl/Hbegftm1Dcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal atrial thrombosis J:83820
Btktm1Wk/Btktm1Wk
Tectm1Welm/Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal platelet physiology J:86448
decreased platelet aggregation J:86448
C1galt1tm1.1Staka/C1galt1tm1.2Staka
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA * DBA/2) 		increased bleeding time J:202276
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae) 		abnormal blood coagulation J:44715
C3tm1Hrc/C3tm1Hrc
Cd55tm1Song/Cd55tm1Song
Cr1ltm1Hmo/Cr1ltm1Hmo
(involves: 129/Sv * 129S6/SvEvTac * 129X1/SvJ) 		abnormal platelet physiology J:138410
C3tm1Hrc/C3tm1Hrc
Cd55tm1Song/Cd55tm1Song
Cr1ltm1Hmo/Cr1ltm1Hmo
Vsig4tm1Gne/Vsig4tm1Gne
(involves: 129/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6N) 		abnormal platelet physiology J:138410
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae) 		abnormal blood coagulation J:44715
Capn1tm1.1Arte/Capn1tm1.1Arte
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6) 		abnormal platelet physiology J:189100
Capn1tm1Ahc/Capn1tm1Ahc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal blood coagulation J:67798
abnormal platelet dense granule physiology J:67798
abnormal platelet physiology J:67798
decreased platelet aggregation J:67798
Cbstm1Unc/Cbstm1Unc
Tg(CBS)11181Eri/0
(involves: 129P2/OlaHsd * C57BL/6J) 		decreased bleeding time J:165612
hypercoagulability J:165612
Ccr3tm1Cge/Ccr3tm1Cge
(involves: 129S4/SvJae * BALB/c) 		abnormal hemostasis J:115273
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe) 		decreased susceptibility to induced thrombosis J:136325
Cd40tm1Kik/Cd40tm1Kik
(B6.129P2-Cd40tm1Kik/J) 		decreased platelet aggregation J:108988
Cd40lgtm1Imx/Y
(B6.129S2-Cd40lgtm1Imx/J) 		decreased platelet aggregation J:108988
Cd40lgtm1Imx/?
(involves: 129S2/SvPas * C57BL/6) 		abnormal thrombosis J:103954
decreased platelet aggregation J:103954
increased bleeding time J:103954
Cd40lgtm1Imx/Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6) 		abnormal blood coagulation J:75152
Cd47tm1Fpl/Cd47tm1Fpl
(B6.129S7-Cd47tm1Fpl) 		abnormal platelet physiology J:98979
Cd47tm1Fpl/Cd47tm1Fpl
(C.129S7-Cd47tm1Fpl) 		abnormal platelet physiology J:98979
Cd59btm1Jha/Cd59btm1Jha
(involves: 129/Sv * C57BL/6) 		abnormal platelet physiology J:82330
Cd151tm1Lka/Cd151tm1Lka
(C57BL/6-Cd151tm1Lka) 		increased bleeding time J:91605
Cdc42tm1Brak/Cdc42tm1Brak
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6) 		abnormal platelet activation J:160792
abnormal platelet dense granule physiology J:160792
abnormal platelet physiology J:160792
increased bleeding time J:160792
increased platelet aggregation J:160792
increased susceptibility to induced thrombosis J:160792
Cfhtm1.1Song/Cfhtm1.1Song
(involves: C57BL/6) 		abnormal blood coagulation J:240426
abnormal brain thrombosis J:240426
abnormal glomerular capillary thrombosis J:240426
abnormal hepatic portal vein thrombosis J:240426
abnormal kidney thrombosis J:240426
abnormal kidney venous thrombosis J:240426
abnormal lung thrombosis J:240426
abnormal thrombosis J:240426
Cfhtm1Mbo/Cfhtm1Mbo
Tg(CAG-Cfh*)#Mcp/0
(involves: 129/Sv * C57BL/6 * CBA) 		abnormal kidney thrombosis J:125860
Clec1btm1.1Arte/Clec1btm1.1Arte
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6) 		abnormal blood coagulation J:217963
abnormal platelet physiology J:181715
Clec1btm1.1Ksi/Clec1btm1.1Ksi
(involves: C57BL/6) 		abnormal platelet activation J:165898
decreased platelet aggregation J:165898
Clec1btm1.2Arte/Clec1btm1.2Arte
(involves: 129 * C57BL/6) 		abnormal platelet physiology J:181754
Clec1btm1.2Arte/Clec1btm1.2Arte
(Not Specified) 		decreased platelet aggregation J:181715
Clec1btm1Mlkn/Clec1btm1Mlkn
(involves: 129S4/SvJae * C57BL/6) 		abnormal platelet activation J:162815
Clic1tm1.1Breit/Clic1tm1.1Breit
(involves: 129 * C57BL/6J) 		abnormal platelet activation J:158394
decreased platelet aggregation J:158394
increased bleeding time J:158394
Cpb2tm1Efp/Cpb2+
Plgtm1Dco/Plg+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:80114
Cpb2tm1Efp/Cpb2+
Plgtm1Dco/Plgtm1Dco
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:80114
Cpb2tm1Efp/Cpb2tm1Efp
(B6.129-Cpb2tm1Efp) 		abnormal blood coagulation J:80114
Cpb2tm1Efp/Cpb2tm1Efp
Plgtm1Dco/Plg+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:80114
Cpb2tm1Efp/Cpb2tm1Efp
Plgtm1Dco/Plgtm1Dco
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:80114
Cpb2tm1Jcmm/Cpb2tm1Jcmm
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal thrombolysis J:102729
Cpb2tm1Mng/Cpb2tm1Mng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:73713, J:107340
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd)) 		abnormal thrombosis J:28201
Dicer1tm1Smr/Dicer1tm1Smr
Tg(Myh6-cre)2182Mds/0
(involves: 129S7/SvEvBrd * FVB/N) 		abnormal atrial thrombosis J:131962
abnormal ventricular thrombosis J:131962
Dock7m/Dock7m
(B6.D(Cg)-Dock7m) 		increased bleeding time J:45425
Dtnbp1sdy/Dtnbp1sdy
(involves: DBA/2J) 		abnormal platelet physiology J:85123, J:323340
decreased platelet aggregation J:85123
increased bleeding time J:1958
Dtnbp1sdy/Dtnbp1sdy
(DBA/2J-Dtnbp1sdy/J) 		increased bleeding time J:14267
E2f3tm1Lees/E2f3tm1Lees
(involves: 129S2/SvPas * C57BL/6) 		abnormal atrial thrombosis J:75765
abnormal cardiac thrombosis J:75765
Emilin1tm1Gmb/Emilin1tm1Gmb
(involves: 129S1/Sv * 129X1/SvJ) 		decreased platelet aggregation J:226863
increased prothrombin time J:226863
Emilin1tm1Gmb/Emilin1tm1Gmb
Emilin2tm1.2Jhp/Emilin2tm1.2Jhp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:226863
decreased platelet aggregation J:226863
Emilin2tm1.2Jhp/Emilin2tm1.2Jhp
(involves: C57BL/6) 		abnormal blood coagulation J:226863
decreased platelet aggregation J:226863
Entpd1tm1Djp/Entpd1tm1Djp
(involves: 129 * C57BL/6) 		abnormal platelet physiology J:76092
Entpd1tm1Djp/Entpd1tm1Djp
(B6.129-Entpd1tm1Djp) 		decreased platelet aggregation J:143010
Entpd1tm1Rdr/Entpd1tm1Rdr
(involves: 129S2/SvPas) 		decreased platelet aggregation J:57505
increased bleeding time J:57505
EpcamGt(RST556)Byg/EpcamGt(RST556)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thrombosis J:155941
Etv6em3Knic/Etv6+
(involves: C57BL/6J) 		impaired blood coagulation J:342774
Exoc3tm2c(EUCOMM)Hmgu/Exoc3tm2c(EUCOMM)Hmgu
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6 * C57BL/6N) 		abnormal platelet physiology J:302300
abnormal thrombosis J:302300
decreased bleeding time J:302300
decreased platelet aggregation J:302300
decreased platelet dense granule secretion J:302300
increased platelet dense granule secretion J:302300
increased susceptibility to induced thrombosis J:302300
F2tm1Jld/F2tm1Sjd
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal blood coagulation J:144572
increased bleeding time J:144572
F2tm1Jld/F2tm1Sjd
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA) 		abnormal blood coagulation J:144572
increased bleeding time J:144572
F2tm1Sjd/F2tm1Sjd
(involves: 129P2/OlaHsd * Black Swiss) 		impaired blood coagulation J:48273
F2tm2Jld/F2+
(B6.129P2-F2tm2Jld) 		decreased susceptibility to induced thrombosis J:174629
increased bleeding time J:174629
F2rl2tm1Cgh/F2rl2tm1Cgh
(involves: 129S4/SvJae * C57BL/6) 		abnormal platelet physiology J:49283
decreased susceptibility to induced thrombosis J:80154
increased bleeding time J:80154
F2rl3tm1.1Cgh/F2rl3tm1.1Cgh
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to induced thrombosis J:80154
increased bleeding time J:80154
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss) 		abnormal blood coagulation J:91165
F3tm1Dco/F3tm1Dco
Tg(F3)1Nmk/0
(B6.Cg-F3tm1Dco Tg(F3)1Nmk) 		abnormal blood coagulation J:88245
F3tm1Dwr/F3+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal blood coagulation J:99260
abnormal thrombosis J:99260
decreased partial thromboplastin time J:99260
F3tm1Dwr/F3tm1Dwr
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal atrial thrombosis J:99260
abnormal cardiac thrombosis J:99260
abnormal thrombosis J:99260
abnormal ventricular thrombosis J:99260
F3tm1Fct/F3tm1Fct
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal blood coagulation J:216519
F3tm1Jld/F3+
(involves: 129P2/OlaHsd * NIH Black Swiss) 		abnormal blood coagulation J:33831
F5tm2Dgi/F5+
(B6.129S2-F5tm2Dgi) 		abnormal blood coagulation J:66260
abnormal thrombosis J:66260
F5tm2Dgi/F5tm2Dgi
(involves: 129S2/SvPas * C57BL/6J) 		abnormal blood coagulation J:66260
abnormal thrombosis J:66260
F5tm2Dgi/F5tm2Dgi
(B6.129S2-F5tm2Dgi) 		abnormal blood coagulation J:66260
F5tm2Dgi/F5tm2Dgi
(involves: 129S2/SvPas * C57BL/6) 		abnormal thrombosis J:62716
F5tm2Dgi/F5tm2Dgi
Proztm1Gjb/Proz+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal thrombosis J:62716
F5tm2Dgi/F5tm2Dgi
Proztm1Gjb/Proztm1Gjb
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal thrombosis J:62716
F7tm1(tTA,tetO-F7)Edr/F7tm1(tTA,tetO-F7)Edr
(B6.129X1-F7tm1(tTA,tetO-F7)Edr) 		abnormal blood coagulation J:144540
increased partial thromboplastin time J:144540
increased prothrombin time J:144540
F7tm1Pec/F7+
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:61481
F7tm1Pec/F7+
Tfpitm1Gjb/Tfpitm1Gjb
(involves: 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:89395
F7tm1Pec/F7tm1Pec
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:61481
F8tm1Kaz/Y
(involves: 129S4/SvJae * C57BL/6) 		abnormal blood coagulation J:24941, J:36698
F8tm1Kaz/F8tm1Kaz
(involves: 129S4/SvJae * C57BL/6) 		abnormal blood coagulation J:36698
F8tm2Kaz/Y
(involves: 129S4/SvJae * C57BL/6) 		abnormal blood coagulation J:24941, J:36698
F8tm2Kaz/Y
(involves: 129S4/SvJae) 		abnormal blood coagulation J:176909
F8tm2Kaz/Y
Tg(Alb-F8)EBmre/0
(involves: 129S4/SvJae * C57BL/6J) 		abnormal blood coagulation J:176909
F9em1Dlli/Y
(involves: C57BL/6J) 		increased partial thromboplastin time J:262204
F9em3Dlli/Y
(involves: C57BL/6J) 		abnormal blood coagulation J:262204
increased partial thromboplastin time J:262204
F9tm1Dws/Y
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal blood coagulation J:44497
F9tm1Dws/Y
(involves: 129P2/OlaHsd) 		abnormal blood coagulation J:166332
increased bleeding time J:166332
F9tm1Dws/F9tm1Dws
(involves: 129P2/OlaHsd) 		abnormal blood coagulation J:166332
increased bleeding time J:166332
F9tm1Emg/Y
(involves: 129S/SvEv * C57BL/6J) 		abnormal blood coagulation J:48501
increased bleeding time J:48501
F9tm1Emg/F9+
(involves: 129S/SvEv * C57BL/6J) 		abnormal blood coagulation J:48501
F9tm1Ver/F9tm1Ver
(involves: 129/Sv * C57BL/6) 		abnormal blood coagulation J:43590
increased bleeding time J:43590
F9tm2(F9)Dws/F9tm2(F9)Dws
(involves: 129S6/SvEvTac * C57BL/6) 		increased bleeding time J:92964
F9tm3Dws/Y
(B6.129P2-F9tm3Dws) 		abnormal blood coagulation J:166332
increased bleeding time J:166332
F9tm3Dws/F9tm3Dws
(B6.129P2-F9tm3Dws) 		increased bleeding time J:166332
F10tm1Ccmt/F10tm1Ccmt
(involves: 129P2/OlaHsd * C57BL/6) 		increased bleeding time J:145092
F11tm1Gjb/F11tm1Gjb
(involves: 129X1/SvJ * C57BL/6) 		decreased platelet aggregation J:100529
increased partial thromboplastin time J:40270
F11tm1Gjb/F11tm1Gjb
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal thrombosis J:67398
F12tm1Fjc/F12tm1Fjc
(involves: 129X1/SvJ * C57BL/6) 		increased partial thromboplastin time J:238837
F13a1tm1Akic/F13a1tm1Akic
(involves: 129P2/OlaHsd * Black Swiss) 		increased bleeding time J:222849
F13a1tm1Gdi/F13a1tm1Gdi
(involves: 129P2/OlaHsd * CBA/Ca) 		abnormal blood coagulation J:87293
increased bleeding time J:87293
F13btm1Akic/F13btm1Akic
(involves: 129P2/OlaHsd * C57BL/6J) 		increased bleeding time J:222849
Fads2tm1Wst/Fads2tm1Wst
(involves: 129P2/OlaHsd) 		abnormal platelet physiology J:140341
decreased platelet aggregation J:140341
decreased susceptibility to induced thrombosis J:140341
increased bleeding time J:140341
Fbln5tm1Eno/Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6) 		increased susceptibility to induced thrombosis J:96831
Fbn1tm1Rmz/Fbn1tm1Rmz
(involves: 129S4/SvJae * C57BL/6J) 		abnormal arterial thrombosis J:43199
Fbxl5tm2.1Kei/Fbxl5tm2.1Kei
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA) 		abnormal blood coagulation J:176655
increased partial thromboplastin time J:176655
increased prothrombin time J:176655
Fcer1atm1Knt/Fcer1atm1Knt
(involves: 129 * BALB/c) 		reduced thrombolysis J:47138
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal platelet activation J:118488
decreased platelet aggregation J:112819
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd) 		decreased platelet aggregation J:165893
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv
Sle16C57BL/6/Sle16C57BL/6
(involves: C57BL/6 * FVB/N) 		abnormal glomerular capillary thrombosis J:179175
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Sle21129P2/Ola/Sle21129P2/Ola
(B6.129S4-Fcgr2btm1Ttk) 		abnormal glomerular capillary thrombosis J:179175
Fermt3tm1.1Efp/Fermt3tm1.1Efp
(involves: C57BL/6) 		abnormal platelet activation J:227094
abnormal platelet physiology J:227094
decreased platelet aggregation J:227094
decreased susceptibility to induced thrombosis J:227094
increased bleeding time J:227094
Fermt3tm1Ref/Fermt3tm1Ref
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal platelet activation J:133659
abnormal thrombosis J:133659
decreased platelet aggregation J:133659
increased bleeding time J:133659
Fgatm1Jld/Fgatm1Jld
(involves: 129P2/OlaHsd * CF-1) 		abnormal blood coagulation J:36591
decreased platelet aggregation J:28436
impaired blood coagulation J:28436
Fgatm1Jld/Fgatm1Jld
(B6.129P2-Fgatm1Jld) 		decreased platelet aggregation J:28436
impaired blood coagulation J:28436
Fgatm1Jld/Fgatm1Jld
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal blood coagulation J:63750
Fgatm1Jld/Fgatm1Jld
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss * CF-1) 		abnormal blood coagulation J:36591
Fgatm1Jld/Fgatm1Jld
Vwftm1Wgr/Vwftm1Wgr
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6J) 		abnormal blood coagulation J:63750
Fggtm1Fjc/Fggtm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:64396
Fggtm1Jld/Fggtm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss) 		decreased platelet aggregation J:36873
increased bleeding time J:36873
Fggtm1Lord/Fgg+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal blood coagulation J:129828
abnormal thrombolysis J:129828
Fggtm1Lord/Fggtm1Lord
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal blood coagulation J:129828
abnormal thrombolysis J:129828
abnormal thrombosis J:129828
Fgl2tm1Pam/Fgl2tm1Pam
(involves: 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:99453
Flnatm1.2Caw/Flna+
(involves: 129S4/SvJae * C57BL/6) 		abnormal thrombosis J:118252
Fn1tm1Ref/Fn1tm1Ref
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased susceptibility to induced thrombosis J:82373
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR)) 		abnormal atrial thrombosis J:11262
Fshrtm1Saco/Fshr+
(involves: 129T2/SvEmsJ) 		abnormal thrombosis J:81460
Fundc2tm1Qim/Fundc2tm1Qim
(involves: C57BL/6) 		decreased susceptibility to induced thrombosis J:301680
Galnt1tm1.1Jxm/Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm) 		increased bleeding time J:128982
Gas2l3tm1d(EUCOMM)Hmgu/Gas2l3tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6J * C57BL/6N) 		abnormal cardiac thrombosis J:244087
Gas6tm1Pec/Gas6tm1Pec
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal platelet dense granule physiology J:77462
decreased platelet aggregation J:77462
decreased susceptibility to induced thrombosis J:77462
Gata1tm6Sho/Gata1tm6Sho
(involves: 129S1/Sv * BALB/c) 		abnormal hemostasis J:115273
Gata3tm1Jeng/Gata3tm1Jeng
(involves: 129S7/SvEvBrd) 		abnormal blood coagulation J:28393
Gdf15tm1Sjl/Gdf15tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased bleeding time J:195443
increased platelet aggregation J:195443
increased susceptibility to induced thrombosis J:195443
Ggcxtm1Sinos/Ggcxtm1Sinos
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ggcxtm1Sinos Speer6-ps1Tg(Alb-cre)21Mgn) 		impaired blood coagulation J:212951
increased bleeding time J:212951
Gm41610em1Scrp/Gm41610em1Scrp
(C57BL/6-Gm41610em1Scrp) 		decreased partial thromboplastin time J:302605
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA * FVB/N) 		abnormal blood coagulation J:99597
abnormal platelet physiology J:99597
decreased platelet aggregation J:99597
increased bleeding time J:99597
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * FVB/N) 		abnormal blood coagulation J:99597
abnormal platelet physiology J:99597
increased bleeding time J:99597
Gna13tm2.2Soff/Gna13tm2.2Soff
Tg(EIIa-cre)C5379Lmgd/?
(involves: FVB) 		abnormal blood coagulation J:99597
abnormal platelet physiology J:99597
increased bleeding time J:99597
Gnaqtm1Soff/Gnaqtm1Soff
(involves: 129S1/Sv * C57BL/6) 		abnormal platelet physiology J:118488, J:42882
increased bleeding time J:42882
Gnaqtm1Soff/Gnaqtm1Soff
(involves: 129S1/Sv) 		decreased platelet aggregation J:114266
Gnaqtm2.1Soff/Gnaqtm2.1Soff
(involves: 129P2/OlaHsd * FVB/N) 		abnormal blood coagulation J:77461
Gnaztm1Lfb/Gnaztm1Lfb
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL) 		decreased platelet aggregation J:77282
decreased susceptibility to induced thrombosis J:77282
Golm1Gt(KST273)Byg/Golm1Gt(KST273)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal glomerular capillary thrombosis J:151282
Gp1batm1Ware/Gp1batm1Ware
(involves: 129S1/Sv * 129X1/SvJ) 		increased bleeding time J:63389
Gp1bbtm1Frla/Gp1bbtm1Frla
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to induced thrombosis J:135065
increased bleeding time J:135065
Gp1bbtm1Ware/Gp1bbtm1Ware
(Not Specified) 		increased bleeding time J:93756
Gp1bbtm2Frla/Gp1bbtm2Frla
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to induced thrombosis J:135065
increased bleeding time J:135065
Gp5tm1Drp/Gp5tm1Drp
(involves: 129X1/SvJ * C57BL/6J) 		decreased bleeding time J:58516
Gp6tm1Beni/Gp6tm1Beni
(involves: 129 * C57BL/6) 		abnormal blood coagulation J:217963
increased bleeding time J:217963
Gp6tm1Beni/Gp6tm1Beni
Clec1btm1.1Arte/Clec1btm1.1Arte
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6) 		increased bleeding time J:217963
Gp6tm1Ware/Gp6tm1Ware
(involves: Black Swiss) 		abnormal blood coagulation J:85315
abnormal platelet activation J:85315
decreased platelet aggregation J:85315
Gpx1tm1Ysh/Gpx1tm1Ysh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal platelet physiology J:41169
Gpx3tm1Jlos/Gpx3+
(B6N.Cg-Gpx3tm1Jlos) 		decreased bleeding time J:183744
increased platelet aggregation J:183744
Gpx3tm1Jlos/Gpx3tm1Jlos
(B6N.Cg-Gpx3tm1Jlos) 		decreased bleeding time J:183744
increased platelet aggregation J:183744
increased susceptibility to induced thrombosis J:183744
Grip1eb/Grip1eb
(involves: ATEB/Le * C57BL/6J) 		abnormal blood coagulation J:64538
Gsntm1Djk/Gsntm1Djk
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6)) 		abnormal platelet activation J:24346
increased bleeding time J:24346
Gucy1a1tm1.1Dko/Gucy1a1tm1.1Dko
(involves: C57BL/6) 		abnormal platelet aggregation J:110362
Gucy1b1tm1.1Frb/Gucy1b1tm1.1Frb
(involves: 129 * C57BL/6 * FVB/N) 		abnormal platelet activation J:121321
Gucy1b1tm1Zhen/Gucy1b1tm1Zhen
Tg(Pf4-icre)Q3Rsko/0
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal platelet physiology J:177066
decreased platelet aggregation J:177066
decreased susceptibility to induced thrombosis J:177066
increased bleeding time J:177066
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl) 		abnormal atrial thrombosis J:88055
Hccstm1Tcc/Hccs+
Nkx2-5tm2(cre)Rph/Nkx2-5+
(involves: 129S1/Sv) 		abnormal atrial thrombosis J:143285
hlb258/?
(involves: 129S4/SvJae * C57BL/6J) 		abnormal blood coagulation J:82961
Hmox1tm1Mlee/Hmox1tm1Mlee
(involves: 129S2/SvPas * BALB/c) 		abnormal thrombosis J:54684
Hmtb1A/J/Hmtb1A/J
(C57BL/6J-Chr 5A/J/Na) 		abnormal thrombosis J:114074
decreased bleeding time J:114074
Hmtb1A/J/Hmtb1C57BL/6J
Hmtb3A/J/Hmtb3C57BL/6J
(involves: C57BL/6J-Chr 5A/J * C57BL/6J-Chr 17A/J) 		abnormal blood coagulation J:114074
abnormal thrombosis J:114074
Hmtb2A/J/Hmtb2A/J
(C57BL/6J-Chr 11A/J/Na) 		abnormal blood coagulation J:114074
Hmtb3A/J/Hmtb3A/J
(C57BL/6J-Chr 17A/J/Na) 		abnormal blood coagulation J:114074
decreased bleeding time J:114074
Hmtb4C57BL/6J/Hmtb4C57BL/6J
(involves: A/J * C57BL/6J) 		abnormal thrombosis J:139651
Hmtb5C57BL/6J/Hmtb5C57BL/6J
(involves: A/J * C57BL/6J) 		increased bleeding time J:139651
Hmtb6A/J/Hmtb6C57BL/6J
(involves: A/J * C57BL/6J) 		abnormal thrombosis J:139651
Hmtb8C57BL/6J/Hmtb8C57BL/6J
(involves: A/J * C57BL/6J) 		abnormal thrombosis J:139651
Hmtb9C57BL/6J/Hmtb9C57BL/6J
(involves: A/J * C57BL/6J) 		abnormal thrombosis J:139651
Hps1ep/Hps1ep
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal platelet physiology J:7327, J:42484
increased bleeding time J:7327
Hps1ep/Hps1ep
(B6.C3Fe-Hps1ep/J) 		increased bleeding time J:7327
Hps3coa-6J/Hps3coa-6J
(C3H/HeJ-Hps3coa-6J/J) 		abnormal blood coagulation J:63693
increased bleeding time J:63693
Hps3coa/Hps3coa
(involves: C57BL/10J) 		abnormal platelet dense granule physiology J:9300
decreased platelet aggregation J:9300
increased bleeding time J:9300
Hps4le/Hps4le
(B6.C3-Pde6brd1 Hps4le) 		abnormal platelet physiology J:11990
increased bleeding time J:7327
Hps4le/Hps4le
Pde6brd1/Pde6brd1
(B6.C3-Pde6brd1 Hps4le/J) 		abnormal platelet activation J:221384
decreased platelet aggregation J:221384
Hps5ru2-mr/Hps5ru2-mr
(B6.Cg-Hps5ru2-mr/Re) 		increased bleeding time J:7327
Hrgtm1Wja/Hrgtm1Wja
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thrombolysis J:134621
decreased bleeding time J:134621
decreased prothrombin time J:134621
Inpp5dtm1Dmt/Inpp5dtm1Dmt
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal blood coagulation J:121283
abnormal platelet activation J:121283
decreased platelet aggregation J:121283
increased bleeding time J:121283
Itga2tm1.1Eck/Itga2+
(involves: 129P2/OlaHsd) 		abnormal platelet physiology J:75683
decreased platelet aggregation J:75683
Itga2tm1.1Eck/Itga2tm1.1Eck
(involves: 129P2/OlaHsd) 		abnormal platelet aggregation J:75683
abnormal platelet physiology J:75683
decreased platelet aggregation J:75683
Itga2tm1.1Tkun/Itga2tm1.1Tkun
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6 * SJL) 		abnormal platelet physiology J:195799
decreased platelet aggregation J:195799
Itga2tm1Ztr/Itga2tm1Ztr
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal platelet physiology J:108331
Itga2btm1(GFP/cre)Emam/Itga2btm1(GFP/cre)Emam
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal platelet physiology J:84564
Itga2btm1Graf/Itga2b+
(B6.Cg-Itga2btm1Graf) 		abnormal platelet activation J:123159
Itga2btm1Tlr/Itga2b+
(either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal platelet activation J:63961
abnormal platelet aggregation J:63961
abnormal platelet physiology J:63961
Itga2btm1Tlr/Itga2btm1Tlr
(either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal blood coagulation J:63961
abnormal hemostasis J:63961
abnormal platelet activation J:63961
abnormal platelet physiology J:63961
decreased platelet aggregation J:63961
increased bleeding time J:63961
Itgb1tm1Ref/Itgb1tm1Ref
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal platelet physiology J:118488
Itgb1tm1Ross/Itgb1tm1Ross
Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * Black Swiss) 		abnormal atrial thrombosis J:82534
Itgb1tm2Mlkn/Itgb1tm2Mlkn
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal platelet physiology J:108331
Itgb3tm1Aja/Itgb3tm1Aja
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal platelet activation J:148306
abnormal platelet dense granule physiology J:148306
abnormal platelet physiology J:148306
decreased susceptibility to induced thrombosis J:148306
increased bleeding time J:148306
Itgb3tm1Drp/Itgb3tm1Drp
(Not Specified) 		abnormal blood coagulation J:73416
Itgb3tm1Hyn/Itgb3tm1.1Wlbcr
Tg(Pf4-icre)Q3Rsko/0
(involves: 129S2/SvPas * C57BL/6) 		abnormal blood coagulation J:224675
abnormal hemostasis J:224675
decreased platelet aggregation J:224675
increased bleeding time J:224675
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6) 		abnormal platelet activation J:52262
increased bleeding time J:52262
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas) 		abnormal platelet physiology J:96049
Itgb3tm1Mgin/Itgb3tm1Mgin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal platelet activation J:123968
increased bleeding time J:123968
Itgb3tm2Mgin/Itgb3tm2Mgin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal platelet activation J:123968
abnormal thrombosis J:129707
increased bleeding time J:123968
Jak2tm1.1Ble/Jak2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca) 		abnormal blood coagulation J:257910
abnormal thrombosis J:257910
Juptm1Kem/Juptm1Kem
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal atrial thrombosis J:38047
abnormal cardiac thrombosis J:38047
abnormal ventricular thrombosis J:38047
KitW-v/KitW-v
(involves: C57BL/6) 		increased bleeding time J:7327
Klkb1tm1Tigm/Klkb1tm1Tigm
(involves: C57BL/6) 		increased partial thromboplastin time J:168556
Kng1tm1Krmc/Kng1tm1Krmc
(either: (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * CD-1)) 		abnormal blood coagulation J:130769
decreased susceptibility to induced thrombosis J:130769
increased partial thromboplastin time J:130769
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal hepatic portal vein thrombosis J:116129
Lattm1.1Mal/Lattm1.1Mal
Rag1tm1Bal/Rag1tm1Bal
(involves: 129S2/SvPas * 129S4/SvJae) 		abnormal platelet dense granule physiology J:125744
decreased platelet aggregation J:125744
Lattm1Bpay/Lattm1Bpay
(involves: 129S2/SvPas) 		abnormal platelet aggregation J:103904
Lattm2.1Mal/Lattm2.1Mal
Rag1tm1Bal/Rag1tm1Bal
(involves: 129S2/SvPas * 129S4/SvJae) 		abnormal platelet dense granule physiology J:125744
abnormal thrombosis J:125744
decreased platelet aggregation J:125744
Lattm4.1Mal/Lattm4.1Mal
(involves: 129P2/OlaHsd) 		abnormal thrombosis J:125744
decreased platelet aggregation J:125744
Lcp2tm1Gak/Lcp2tm1Gak
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal platelet activation J:162815
decreased platelet aggregation J:162815
Lcp2tm1Gak/Lcp2tm2Gak
Tg(Pf4-icre)Q3Rsko/0
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal platelet activation J:162815
Lims1tm1.1Chen/Lims1tm1.1Chen
Lims2tm1.1Chen/Lims2tm1.1Chen
Tg(Tnnt2-cre)5Blh/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		abnormal atrial thrombosis J:167114
LnpkUl/Lnpk+
(B6EiC3-+ a/LnpkUl A/J) 		increased bleeding time J:31800
Ly6atm1Pmf/Ly6atm1Pmf
(B6.129P2-Ly6atm1Pmf) 		increased bleeding time J:81387
Lystbg-J/Lystbg-J
(C57BL/6J-Lystbg-J/J) 		increased bleeding time J:7327
Mcpt4tm1Mabr/Mcpt4tm1Mabr
(involves: 129X1/SvJ * C57BL/6J) 		abnormal blood coagulation J:84839
Mertktm1Lex/Mertktm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased platelet aggregation J:102333
decreased susceptibility to induced thrombosis J:102333
Mfap2tm1Mech/Mfap2+
(B6.129X1-Mfap2tm1Mech) 		decreased susceptibility to induced thrombosis J:134343
Mfap2tm1Mech/Mfap2tm1Mech
(B6.129X1-Mfap2tm1Mech) 		decreased susceptibility to induced thrombosis J:134343
increased bleeding time J:134343
Mfngtm1.1Cfg/Mfngtm1.1Cfg
(involves: C57BL/6) 		decreased partial thromboplastin time J:217719
decreased prothrombin time J:217719
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased partial thromboplastin time J:80661
Mgat4btm1.1Jxm/Mgat4btm1.1Jxm
(B6.129-Mgat4btm1.1Jxm) 		increased bleeding time J:212313
increased partial thromboplastin time J:212313
Mink1tm1.2Lgrl/Mink1tm1.2Lgrl
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal platelet dense granule physiology J:231551
abnormal platelet physiology J:231551
decreased platelet aggregation J:231551
decreased susceptibility to induced thrombosis J:231551
increased bleeding time J:231551
Mir1a-2tm1Dsr/Mir1a-2tm1Dsr
(involves: 129/Sv * C57BL/6) 		abnormal atrial thrombosis J:211548
Mir133a-1tm1Eno/Mir133a-1tm1Eno
Mir133a-2tm1Eno/Mir133a-2tm1Eno
(involves: 129S/SvEv * C57BL/6) 		abnormal atrial thrombosis J:142220
MitfMi-wh/MitfMi-wh
(B6.Cg-MitfMi-wh) 		decreased bleeding time J:7327
Mlphln/Mlphln
Sgk3fz/Sgk3fz
(C57BL/6J-Sgk3fz Mlphln) 		decreased bleeding time J:7327
Mpig6btm1.1Arte/Mpig6btm1.1Arte
(involves: C57BL/6NTac) 		abnormal platelet physiology J:201266
decreased platelet aggregation J:201266
increased bleeding time J:201266
Mplhlb219/Mplhlb219
(C57BL/6J-Mplhlb219/J) 		increased bleeding time J:146577
Myh6tm1Jse/Myh6+
Tg(Myh6-TNNI3*G203S)1Chs/0
(involves: 129X1/SvJ * C57BL/6) 		abnormal atrial thrombosis J:153302
Myh6tm1Jse/Myh6tm1Jse
(involves: 129X1/SvJ * Black Swiss) 		abnormal atrial thrombosis J:51939
Myh9tm1.1(MYH9*)Mjk/Myh9+
(B6.Cg-Myh9tm1.1(MYH9*)Mjk) 		increased bleeding time J:175367
Myh9tm1.1(MYH9*)Mjk/Myh9tm1.1(MYH9*)Mjk
(B6.129-Myh9tm1.1(MYH9*)Mjk) 		increased bleeding time J:175367
Myh9tm1.1Gac/Myh9+
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6) 		abnormal platelet physiology J:148233
Myh9tm1.1Gac/Myh9tm1.1Gac
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6) 		abnormal blood coagulation J:148233
abnormal platelet physiology J:148233
increased bleeding time J:148233
Myh9tm6.1(EGFP/MYH9*)Rsad/Myh9+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6) 		abnormal blood coagulation J:175367
increased bleeding time J:175367
Myh9tm7.1Rsad/Myh9+
(involves: BALB/cJ) 		increased bleeding time J:175367
Myh9tm7.1Rsad/Myh9tm7.1Rsad
(involves: BALB/cJ) 		increased bleeding time J:175367
Myh10tm7Rsad/Myh10tm7Rsad
Tg(Myh6-cre)2182Mds/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N) 		abnormal atrial thrombosis J:170148
Myl2tm1(cre)Krc/Myl2+
Pip5k1ctm2Csab/Pip5k1ctm2Csab
(Not Specified) 		abnormal platelet aggregation J:196476
abnormal platelet physiology J:196476
Myl2tm1(cre)Krc/Myl2+
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae) 		abnormal atrial thrombosis J:96138
Myocdtm1Msp/Myocdtm1Msp
Tg(Myh6-cre)2182Mds/0
(involves: 129/Sv * FVB/N) 		abnormal atrial thrombosis J:154666
abnormal cardiac thrombosis J:154666
Nbeal2tm1Lex/Nbeal2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal platelet activation J:201413
decreased platelet aggregation J:201413
decreased susceptibility to induced thrombosis J:201413
increased bleeding time J:201413
Ncoa6tm1Jkr/Ncoa6tm1Jkr
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal atrial thrombosis J:269856
Nexntm1.1Chen/Nexntm1.1Chen
(Not Specified) 		abnormal ventricular thrombosis J:290931
Nexntm1Chen/Nexntm1Chen
Tg(myl7.L-cre)1118Tmhn/0
(involves: MF1) 		abnormal ventricular thrombosis J:290931
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd) 		abnormal glomerular capillary thrombosis J:100308
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau) 		abnormal blood coagulation J:117987
abnormal platelet physiology J:117987
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd) 		abnormal platelet aggregation J:120499
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J) 		abnormal glomerular capillary thrombosis J:148626
Notch3tm1.1Dwr/Notch3+
(involves: 129S/SvEv * Swiss) 		abnormal brain thrombosis J:191454
Notch3tm1.1Dwr/Notch3tm1.1Dwr
(involves: 129S/SvEv * Swiss) 		abnormal brain thrombosis J:191454
Nr3c1tm1.1Jaci/Nr3c1tm1.1Jaci
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6 * FVB/N) 		abnormal atrial thrombosis J:201995
Nt5etm1Jsc/Nt5etm1Jsc
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal platelet physiology J:102299
decreased bleeding time J:102299
increased susceptibility to induced thrombosis J:102299
Or2l13bem1Scjc/Or2l13bem1Scjc
(FVB/NTac-Or2l13bem1Scjc) 		abnormal platelet activation J:324598
Orai1tm1Fesk/Orai1tm1Fesk
(C57BL/6-Orai1tm1Fesk) 		abnormal platelet activation J:144861
P2ry1tm1Bhk/P2ry1tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal thrombolysis J:57960
decreased platelet aggregation J:57960
increased bleeding time J:57960
P2ry1tm1Gac/P2ry1+
(involves: 129S2/SvPas * C57BL/6) 		decreased platelet aggregation J:59055
P2ry1tm1Gac/P2ry1tm1Gac
(involves: 129S2/SvPas * C57BL/6) 		decreased platelet aggregation J:59055
decreased susceptibility to induced thrombosis J:59055
increased bleeding time J:59055
P2ry12tm1Cjf/P2ry12tm1Cjf
(involves: 129) 		decreased platelet aggregation J:70017
increased bleeding time J:70017
P2ry12tm1Pcon/P2ry12tm1Pcon
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal platelet physiology J:84917
decreased platelet aggregation J:84917
decreased susceptibility to induced thrombosis J:84917
increased bleeding time J:84917
P3h2tm1Hpb/P3h2tm1Hpb
(involves: 129 * C57BL/6J) 		abnormal thrombosis J:206377
P4hbtm1.1Geno/P4hbtm1.1Geno
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA/J) 		decreased platelet aggregation J:229395
decreased susceptibility to induced thrombosis J:229395
P4hbtm1.1Geno/P4hbtm1.1Geno
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6) 		abnormal platelet dense granule physiology J:229395
decreased platelet aggregation J:229395
decreased susceptibility to induced thrombosis J:229395
increased bleeding time J:229395
Papss2bm/Papss2bm
(B6C3Fe a/a-Papss2bm/J) 		increased bleeding time J:31800
Pdgfrbtm5Sor/Pdgfrbtm5Sor
(either: 129S4/SvJaeSor-Pdgfratm5Sor or (involves: 129S4/SvJaeSor * C57BL/6)) 		abnormal glomerular capillary thrombosis J:67735
Pdia4tm1b(EUCOMM)Wtsi/Pdia4tm1b(EUCOMM)Wtsi
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6N) 		decreased platelet aggregation J:244748
Pdia4tm1b(EUCOMM)Wtsi/Pdia4tm1b(EUCOMM)Wtsi
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6N) 		decreased platelet aggregation J:244748
increased bleeding time J:244748
Pdlim1Gt(IST12013D3)Tigm/Pdlim1Gt(IST12013D3)Tigm
(involves: C57BL/6N) 		abnormal platelet physiology J:212221
abnormal thrombosis J:212221
increased platelet aggregation J:212221
Pdlim1Gt(XC262)Byg/Pdlim1Gt(XC262)Byg
(involves: 129P2/OlaHsd) 		abnormal platelet dense granule physiology J:212221
abnormal platelet physiology J:212221
abnormal thrombosis J:212221
increased platelet aggregation J:212221
Pdlim7Gt(OST445990)Lex/Pdlim7+
(B6.129S5-Pdlim7Gt(OST445990)Lex) 		abnormal cardiac thrombosis J:209780
decreased bleeding time J:209780
Pdlim7Gt(OST445990)Lex/Pdlim7Gt(OST445990)Lex
(B6.129S5-Pdlim7Gt(OST445990)Lex) 		abnormal cardiac thrombosis J:209780
abnormal thrombosis J:209780
decreased bleeding time J:209780
Pear1tm1a(KOMP)Wtsi/Pear1tm1a(KOMP)Wtsi
(involves: C57BL/6N) 		decreased platelet aggregation J:237835
Pex1tm1.1Hrw/Pex1tm1.1Hrw
(involves: C57BL/6NTac) 		abnormal venous thrombosis J:278655
Pf4tm1Mako/Pf4+
(B6.129X1-Pf4tm1Mako) 		decreased susceptibility to induced thrombosis J:94900
Pf4tm1Mako/Pf4tm1Mako
(B6.129X1-Pf4tm1Mako) 		decreased susceptibility to induced thrombosis J:94900
Pik3c2atm1Bvan/Pik3c2a+
(involves: C57BL/6) 		abnormal platelet physiology J:226344
decreased platelet aggregation J:226344
decreased susceptibility to induced thrombosis J:226344
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(involves: 129P2/OlaHsd) 		abnormal platelet physiology J:152267
decreased platelet aggregation J:152267
Pik3cbtm1Bvan/Pik3cbtm1Bvan
Tg(Pf4-icre)Q3Rsko/0
(involves: 129P2/OlaHsd) 		decreased platelet aggregation J:158839
Pik3cdtm1.1Bvan/Pik3cdtm1.1Bvan
(B6.129P2-Pik3cdtm1.1Bvan) 		abnormal platelet aggregation J:114310
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(involves: 129S4/SvJae * C57BL/6J) 		abnormal platelet aggregation J:114310
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Pik3cgtm1Dwu) 		abnormal platelet physiology J:107460
decreased platelet aggregation J:107460
decreased susceptibility to induced thrombosis J:107460
Pik3cgtm1Ehi/Pik3cgtm1Ehi
(Not Specified) 		decreased platelet aggregation J:152267
Pip5k1ctm1Csab/Pip5k1ctm1Csab
Tg(Pf4-icre)Q3Rsko/0
(Not Specified) 		abnormal platelet physiology J:196476
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to induced thrombosis J:17427
reduced thrombolysis J:17427
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg) 		reduced thrombolysis J:64220
Plattm1Mlg/Plattm1Mlg
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		abnormal thrombosis J:17427
reduced thrombolysis J:17427
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6) 		abnormal thrombosis J:17427
increased susceptibility to induced thrombosis J:17427
Plautm1Mlg/Plautm1Mlg
(either: B6.Cg-Plautm1Mlg or (involves: Black Swiss * C57BL/6)) 		reduced thrombolysis J:64220
Plcb2tm1Dwu/Plcb2tm1Dwu
Plcb3tm1Dwu/Plcb3tm1Dwu
(involves: 129S1/Sv * CD-1) 		abnormal platelet physiology J:60348
decreased platelet aggregation J:60348
decreased susceptibility to induced thrombosis J:60348
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd) 		decreased platelet aggregation J:114266
Pld1tm1.1Mafr/Pld1tm1.1Mafr
(B6.Cg-Pld1tm1.1Mafr) 		abnormal platelet physiology J:193451
Pld1tm3Mafr/Pld1tm3Mafr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased platelet aggregation J:211547
Pld1tm3Mafr/Pld1tm3Mafr
(B6.129-Pld1tm3Mafr) 		abnormal platelet activation J:216114
Pld1tm3Mafr/Pld1tm3Mafr
Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac) 		abnormal platelet activation J:216114
decreased susceptibility to induced thrombosis J:216114
Plektm1Csab/Plektm1Csab
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal platelet activation J:148429
decreased platelet aggregation J:148429
Plgtm1Dco/Plg+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:80114
Plgtm1Dco/Plg+
(involves: 129S2/SvPas * C57BL/6J) 		abnormal blood coagulation J:30174
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		abnormal blood coagulation J:80114
Plgtm1Dco/Plgtm1Dco
(involves: 129S2/SvPas * C57BL/6J) 		abnormal blood coagulation J:30174
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * NIH Black Swiss) 		abnormal thrombosis J:39419
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd * Black Swiss) 		abnormal kidney thrombosis J:36591
abnormal thrombosis J:36591
Ppp1r13ltm1.1Xlu/Ppp1r13ltm1.1Xlu
(involves: 129 * C57BL/6J) 		abnormal cardiac thrombosis J:220162
Ppp1r13lwa3/Ppp1r13lwa3
(either: C57BL/6-Ppp1r13lwa3 or (involves: C57BL/6 * DBA/2J)) 		abnormal arterial thrombosis J:96392
Prdx6tm1Pgn/Prdx6tm1Pgn
(either: 129/Sv or (involves: 129/Sv * C57BL/6)) 		abnormal blood coagulation J:84376
abnormal kidney venous thrombosis J:84376
abnormal venous thrombosis J:84376
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal platelet activation J:144254
abnormal platelet dense granule physiology J:144254
abnormal platelet physiology J:144254
increased platelet aggregation J:144254
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		abnormal blood coagulation J:50527
abnormal brain thrombosis J:50527
abnormal cardiac thrombosis J:50527
abnormal lung thrombosis J:50527
Procrtm1.1Pcl/Procrtm1.1Pcl
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to induced thrombosis J:225914
Procrtm1Cte/Procr+
(B6.129S7-Procrtm1Cte) 		abnormal blood coagulation J:144388
Procrtm1Cte/Procrtm1Cte
(either: 129S/SvEv-Procrtm1Cte or (involves: 129S7/SvEvBrd * Black Swiss)) 		abnormal blood coagulation J:80043
abnormal placental thrombosis J:80043
Pros1tm1.1Ansc/Pros1+
(involves: 129/Sv * C57BL/6J * FVB/N) 		increased susceptibility to induced thrombosis J:152423
Pros1tm1.1Ansc/Pros1tm1.1Ansc
(involves: 129/Sv * C57BL/6J * FVB/N) 		abnormal thrombosis J:152423
Pros1tm1.2Grl/Pros1+
(involves: 129S1/SvImJ * FVB/N) 		decreased bleeding time J:198769
Pros1tm1.2Grl/Pros1tm1.2Grl
(involves: 129S1/SvImJ * FVB/N) 		abnormal blood coagulation J:198769
abnormal thrombosis J:198769
Pros1tm1Grl/Pros1tm1Grl
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/SvImJ * C57BL/6 * DBA) 		abnormal thrombosis J:198769
Pros1tm1Grl/Pros1tm1Grl
Tg(Tek-cre)1Ywa/0
(involves: 129S1/SvImJ * C57BL/6 * SJL) 		abnormal thrombosis J:198769
Prox1tm2Gco/Prox1tm2Gco
Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S1/Sv * 129S7/SvEvBrd) 		abnormal atrial thrombosis J:212185
abnormal cardiac thrombosis J:212185
abnormal ventricular thrombosis J:212185
Proztm1Gjb/Proztm1Gjb
(involves: 129X1/SvJ) 		increased susceptibility to induced thrombosis J:136102
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA) 		abnormal platelet activation J:165893
decreased bleeding time J:165893
increased platelet aggregation J:165893
Ptger3tm1Cof/Ptger3tm1Cof
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to induced thrombosis J:125376
Ptgirtm1Sna/Ptgirtm1Sna
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal blood coagulation J:42275
abnormal platelet activation J:79049
increased susceptibility to induced thrombosis J:42275, J:108957
Ptgs1tm1Fun/Ptgs1tm1Fun
(involves: 129S6/SvEvTac * C57BL/6) 		decreased platelet aggregation J:97351
decreased susceptibility to induced thrombosis J:97351
increased bleeding time J:97351
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal blood coagulation J:29511
decreased platelet aggregation J:29511
Ptgs2tm1Fun/Ptgs2tm1Fun
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal blood coagulation J:108957
abnormal platelet physiology J:108957
abnormal thrombolysis J:108957
decreased susceptibility to induced thrombosis J:108957
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal thrombosis J:109021
Ptgs2tm3Fun/Ptgs2tm3Fun
(involves: 129S6/SvEvTac * C57BL/6J) 		increased platelet aggregation J:148699
increased susceptibility to induced thrombosis J:148699
Ptpn9tm1Dny/Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny) 		abnormal platelet physiology J:118880
decreased platelet aggregation J:118880
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6) 		increased bleeding time J:72267
Rab27aash/Rab27aash
(involves: C3H/HeDiSn) 		increased bleeding time J:63231
Rab27aash/Rab27aash
(C3H/HeSn-Rab27aash/J) 		abnormal platelet dense granule physiology J:77395
decreased platelet aggregation J:77395
increased bleeding time J:77395
Rab27aash/Rab27aash
Rab27btm1.2Seab/Rab27btm1.2Seab
(involves: 129X1/SvJ * C3H/HeSn * C57BL/6J) 		abnormal blood coagulation J:120307
abnormal platelet dense granule physiology J:120307
decreased platelet aggregation J:120307
Rab27btm1.2Seab/Rab27btm1.2Seab
(involves: 129X1/SvJ * C57BL/6J) 		abnormal blood coagulation J:120307
abnormal platelet dense granule physiology J:120307
decreased platelet aggregation J:120307
Rab32tm1b(KOMP)Wtsi/Rab32tm1b(KOMP)Wtsi
Rab38tm1.1Ics/Rab38tm1.1Ics
(involves: C57BL/6N * C57BL/6NTac) 		decreased platelet aggregation J:293385
decreased susceptibility to induced thrombosis J:293385
increased bleeding time J:293385
Rabggtagm/Rabggtagm
(C57BL/6J-Rabggtagm) 		increased bleeding time J:12434
Rac1tm1Djk/Rac1tm1Djk
Tg(Pf4-icre)Q3Rsko/0
(involves: 129S4/SvJae * C57BL/6) 		abnormal platelet activation J:214607
decreased platelet aggregation J:214607
Ranbp10Gt(RRZ226)Byg/Ranbp10Gt(RRZ226)Byg
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6)) 		abnormal platelet dense granule physiology J:193236
decreased platelet aggregation J:193236
increased bleeding time J:193236
Rap1btm1Gwht/Rap1btm1Gwht
(involves: 129S/SvEv * C57BL/6) 		decreased platelet aggregation J:96758
decreased susceptibility to induced thrombosis J:96758
increased bleeding time J:96758
Rasa3hlb381/Rasa3hlb381
(C57BL/6J-Rasa3hlb381/J) 		abnormal platelet physiology J:221899
Rasa3hlb381/Rasa3hlb381
Rasgrp2tm1Amg/Rasgrp2tm1Amg
(involves: C57BL/6J) 		abnormal hemostasis J:221899
Rasgrp2tm1Amg/Rasgrp2tm1Amg
(Not Specified) 		abnormal platelet physiology J:92864
decreased platelet aggregation J:122618, J:92864
increased bleeding time J:92864
Rce1tm2Kim/Rce1tm2.1Kim
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6) 		abnormal atrial thrombosis J:87958
Rgs18m1H/Rgs18m1H
(BALB/cAnN-Rgs18m1H/H) 		abnormal hemostasis J:228457
decreased bleeding time J:228457
increased platelet aggregation J:228457
increased susceptibility to induced thrombosis J:228457
Rgs18tm1.1Ics/Rgs18tm1.1Ics
(involves: 129S2/SvPas * C57BL/6J) 		increased platelet aggregation J:225296
Rhbdf1tm1.1Mfm/Rhbdf1tm1.1Mfm
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J) 		abnormal cardiac thrombosis J:203951
Rnase1tm1.2Rtrs/Rnase1tm1.2Rtrs
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6) 		abnormal blood coagulation J:288762
RplagFVB/NJ/?
(involves: C57BL/6J * FVB/NJ) 		abnormal platelet physiology J:90287
Rr29Hx/Rr29+
(B10.D2/nSn-Rr29Hx/J) 		increased bleeding time J:31800
Ryr2tm1Krbr/Ryr2tm1Krbr
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal atrial thrombosis J:210083
Scube1tm2.1Rbya/Scube1tm2.1Rbya
(Not Specified) 		decreased platelet aggregation J:223899
decreased susceptibility to induced thrombosis J:223899
increased bleeding time J:223899
Selltm1.1Rpmc/Selltm1.1Rpmc
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		increased susceptibility to induced thrombosis J:249558
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6J) 		increased bleeding time J:31431
Selptm2Hyn/Selptm2Hyn
(involves: 129S2/SvPas * C57BL/6J) 		abnormal blood coagulation J:125020
Selplgtm1Rpmc/Selplgtm1Rpmc
(involves: 129S1/Sv * C57BL/6J) 		increased bleeding time J:138731
Selplgtm2Rpmc/Selplgtm2Rpmc
(B6.Cg-Selplgtm2Rpmc) 		increased bleeding time J:138731
Sema3atm1Mcf/Sema3atm1Mcf
(involves: 129S4/SvJae) 		abnormal atrial thrombosis J:35824
Septin5tm1Wtr/Septin5tm1Wtr
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal platelet physiology J:109519
increased platelet aggregation J:109519
Serpina10tm1Gjb/Serpina10tm1Gjb
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to induced thrombosis J:136102
Serpinc1tm1Dwr/Serpinc1+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal cardiac thrombosis J:115658
Serpinc1tm1Dwr/Serpinc1tm1Dwr
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal atrial thrombosis J:115658
abnormal blood coagulation J:115658
abnormal cardiac thrombosis J:115658
abnormal placental thrombosis J:115658
abnormal thrombosis J:115658
Serpinc1tm1Sai/Serpinc1+
(involves: 129S2/SvPas * C57BL/6J) 		increased susceptibility to induced thrombosis J:75955
Serpinc1tm1Sai/Serpinc1tm1Sai
(involves: 129S2/SvPas * C57BL/6J) 		abnormal thrombosis J:65092
Serpind1tm1Moto/Serpind1+
(B6.Cg-Serpind1tm1Moto) 		abnormal platelet aggregation J:122173
increased susceptibility to induced thrombosis J:122173
Serpind1tm1Toll/Serpind1tm1Toll
(involves: 129X1/SvJ * C57BL/6) 		increased susceptibility to induced thrombosis J:74337
Serpinf2tm1Hrl/Serpinf2tm1Hrl
(involves: 129X1/SvJ * C57BL/6J) 		abnormal blood coagulation J:54047
abnormal thrombolysis J:54047
Slc7a11sut/Slc7a11sut
(C3H/HeSnJ-Slc7a11sut/J) 		increased bleeding time J:31616
Slc9a8Gt(YHB273)Byg/Slc9a8Gt(YHB273)Byg
(involves: 129P2/OlaHsd * Black Swiss) 		abnormal blood coagulation J:191151
Slfn14em1Nvm/Slfn14+
(C57BL/6J-Slfn14em1Nvm) 		abnormal thrombosis J:325381
Slpitm1Smw/Slpitm1Smw
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal platelet physiology J:95293
Smad6tm1Glvn/Smad6tm1Glvn
(involves: 129S6/SvEvTac * BALB/cByJ) 		abnormal thrombosis J:60214
Spta1sph-2Bc/Spta1sph-2Bc
((WB.Cg-Spta1sph-2Bc/Brk x B6.Cg-Spta1sph-2Bc/Brk)F1) 		abnormal cardiac thrombosis J:62355
Spta1sph-Dem/Spta1sph-Dem
(CcS3/Dem-Spta1sph-Dem) 		abnormal cardiac thrombosis J:62355
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1) 		abnormal thrombosis J:12830
Spta1sph-ha/Spta1sph-ha
((WB.D1-Spta1sph-ha/Brk x B6.D1-Spta1sph-ha/Brk)F1) 		abnormal cardiac thrombosis J:62355
Spta1sph/Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1) 		abnormal cardiac thrombosis J:62355, J:44313
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1) 		abnormal cardiac thrombosis J:62355, J:44313
St3gal2tm1Jxm/St3gal2tm1Jxm
(Not Specified) 		increased bleeding time J:217719
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(B6.129-St3gal4tm1.1Jxm) 		abnormal platelet physiology J:136946
increased bleeding time J:136946
Stat3tm1Vpo/Stat3tm1Vpo
Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal atrial thrombosis J:141591
Stim1Gt(RRS558)Byg/Stim1Gt(RRS558)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal platelet activation J:137364
abnormal thrombosis J:137364
decreased platelet aggregation J:137364
Stim1Sax/Stim1+
(involves: C3HeB/FeJ * C57BL/6) 		abnormal platelet activation J:127381
abnormal thrombosis J:127381
increased bleeding time J:127381
Stim1tm1.1Pg/Stim1+
(involves: C57BL/6) 		increased bleeding time J:285187
Stim1tm3Ics/Stim1+
(involves: C57BL/6N) 		increased bleeding time J:277842
Sting1em1Jmin/Sting1+
(involves: C57BL/6N) 		abnormal lung thrombosis J:251372
Stx8tm2a(EUCOMM)Wtsi/Stx8tm2a(EUCOMM)Wtsi
(involves: C57BL/6N) 		abnormal platelet dense granule physiology J:218388
abnormal platelet physiology J:218388
abnormal thrombosis J:218388
decreased platelet aggregation J:218388
Stxbp5ltm1.1Aljg/Stxbp5ltm1.1Aljg
(involves: C57BL/6J) 		increased partial thromboplastin time J:263474
Sult1e1tm1Song/Sult1e1tm1Song
(B6.129S6-Sult1e1tm1Song) 		abnormal placental thrombosis J:96050
abnormal platelet physiology J:96050
SvilGt(RRF043)Byg/SvilGt(RRF043)Byg
(B6.129P2-SvilGt(RRF043)Byg) 		abnormal platelet physiology J:198612
increased platelet aggregation J:198612
Syktm1.1Nns/Syktm1.1Nns
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6) 		abnormal platelet physiology J:181715
Tbptm1.1Ees/Tbptm1.1Ees
(B6.129X1(Cg)-Tbptm1.1Ees) 		abnormal blood coagulation J:77714
Tbxa2rtm1Cof/Tbxa2rtm1Cof
(either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * 129S/SvEv)) 		abnormal platelet aggregation J:52125
increased bleeding time J:52125
Tbxa2rtm1Cof/Tbxa2rtm1Cof
(C.129P2(B6)-Tbxa2rtm1Cof) 		abnormal platelet physiology J:79049
Tbxas1tm1Swl/Tbxas1+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J) 		decreased platelet aggregation J:90922
increased bleeding time J:90922
Tbxas1tm1Swl/Tbxas1tm1Swl
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J) 		decreased platelet aggregation J:90922
increased bleeding time J:90922
Tcf3tm1(TCF3/HLF)Homy/Tcf3+
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal thrombosis J:160392
Tectm1Welm/Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased platelet aggregation J:86448
Tfpitm1.1Rdsi/Tfpitm1.1Rdsi
Tg(Tek-cre)12Flv/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * BALB/cJ * C3H * C57BL/6) 		increased susceptibility to induced thrombosis J:164530
Tfpitm1Gjb/Tfpitm1Gjb
(involves: 129) 		abnormal blood coagulation J:51137
abnormal thrombosis J:51137
Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh) 		abnormal atrial thrombosis J:92579
Tg(CAG-Map3k7*K63W)1232Mds/0
Tg(Myh6-cre)2182Mds/0
(involves: FVB/N) 		abnormal atrial thrombosis J:117108
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB) 		abnormal atrial thrombosis J:80609
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB) 		abnormal atrial thrombosis J:80609
Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB) 		abnormal atrial thrombosis J:80609
Tg(CAG-NRIP1)51Row/0
(involves: FVB/N) 		abnormal atrial thrombosis J:175885
Tg(CAMalpha1b)7Wjk/?
(Not Specified) 		abnormal atrial thrombosis J:134704
Tg(FCGR2A)11Mkz/0
Tg(PF4)#Zcy/0
(involves: C57BL/6 * SJL) 		increased susceptibility to induced thrombosis J:72220
Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6) 		abnormal lung thrombosis J:288386
Tg(JAK2*V617F)FF1Rsko/0
Tg(Tek-cre)1Arnd/0
(involves: C57BL/6 * CBA * DBA/2) 		abnormal blood coagulation J:206659
decreased platelet aggregation J:206659
decreased susceptibility to induced thrombosis J:206659
increased bleeding time J:206659
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J) 		abnormal brain thrombosis J:294084
Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea) 		abnormal glomerular capillary thrombosis J:72982
Tg(Myh6*)1Lnwd/0
(involves: C57BL/6 * FVB/N) 		abnormal cardiac thrombosis J:55938
Tg(Myh6*)1Lnwd/Tg(Myh6*)1Lnwd
(involves: C57BL/6 * FVB/N) 		abnormal cardiac thrombosis J:55938
Tg(Myh6-1810058I24Rik)#Eno/0
(involves: C57BL/6) 		abnormal atrial thrombosis J:325962
Tg(Myh6-ANKRD1)#Camm/0
(involves: FVB) 		abnormal atrial thrombosis J:302922
Tg(Myh6-BRUNOL4*)10Coop/0
(involves: FVB) 		abnormal atrial thrombosis J:99369
Tg(Myh6-CACNA1C)M1Aschw/0
(involves: FVB/N) 		abnormal atrial thrombosis J:134761
Tg(Myh6-Camk2d_ic)LJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6)) 		abnormal atrial thrombosis J:130644
Tg(Myh6-Camk2d_ic)MJhb/0
(either: (involves: Black Swiss) or (involves: C57BL/6)) 		abnormal atrial thrombosis J:130644
Tg(Myh6-cre)TG9Pjay/0
(involves: FVB/N) 		abnormal atrial thrombosis J:198043
Tg(Myh6-CREB1*S133A)1Jml/0
(involves: CD-1) 		abnormal atrial thrombosis J:133881
abnormal thrombosis J:133881
Tg(Myh6-Cryab*R120G)708Rbns/0
(FVB/N-Tg(Myh6-Cryab*R120G)708Rbns) 		abnormal atrial thrombosis J:133093
Tg(Myh6-CRYAB*R120G)7302Ijb/0
(involves: C57BL/6) 		abnormal atrial thrombosis J:126781
Tg(Myh6-Gnaq*Q209L)44Ejne/Tg(Myh6-Gnaq*Q209L)44Ejne
(involves: FVB) 		abnormal atrial thrombosis J:127756
Tg(Myh6-Gnaq*Q209L)52Ejne/?
(involves: FVB) 		abnormal atrial thrombosis J:204274
Tg(Myh6-HBEGF)#Iko/0
(involves: C57BL/6 * DBA/2) 		abnormal atrial thrombosis J:93335
Tg(Myh6-Mef2d)2Eno/0
(Not Specified) 		abnormal thrombosis J:130825
Tg(Myh6-Murc)#Tue/0
(Not Specified) 		abnormal atrial thrombosis J:136004
Tg(Myh6-Prkaca)2Eno/0
(Not Specified) 		abnormal atrial thrombosis J:263774
Tg(Myh6-Prkaca)33Eno/0
(Not Specified) 		abnormal atrial thrombosis J:263774
Tg(Myh6-Rxra)41Pcn/0
(Not Specified) 		abnormal cardiac thrombosis J:60351
Tg(Myh6-STK4)28Jusa/0
(involves: C57BL/6) 		abnormal atrial thrombosis J:139414
Tg(Myh6-TEAD4)3Afrs/0
(involves: FVB) 		abnormal atrial thrombosis J:112740
Tg(Myh6-Tmod1)65Msus/Tg(Myh6-Tmod1)65Msus
(involves: FVB/N) 		abnormal atrial thrombosis J:107823
Tg(Myh6-Tnf)1Brgi/?
(involves: C57BL/6J * SJL) 		abnormal atrial thrombosis J:100006
Tg(Myh6-Tnf)2Brgi/?
(involves: C57BL/6J * SJL) 		abnormal atrial thrombosis J:100006
Tg(Myh6-TNNT2*R141W)#Lian/0
(involves: C57BL/6J) 		abnormal thrombosis J:211769
Tg(Myh6-Tpm1*D175N)#Dfw/0
(Not Specified) 		abnormal atrial thrombosis J:57365
Tg(Myh6-Tpm1*E180G)57Dfw/0
(involves: FVB/N) 		abnormal atrial thrombosis J:127507
Tg(Myh6-tTA)6Smbf/0
Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA) 		abnormal atrial thrombosis J:128617
Tg(Myh7-Phc1)#Yota/0
(involves: C57BL/6) 		abnormal atrial thrombosis J:75968
Tg(Myh7-Ptpn11*Q79R)11Rbns/0
(FVB.Cg-Tg(Myh7-Ptpn11*Q79R)11Rbns) 		abnormal atrial thrombosis J:123963
Tg(Myh7-RARA/lacZ)30Mcco/0
(Not Specified) 		abnormal atrial thrombosis J:146424
Tg(Myh7-RARA/lacZ)32Mcco/0
(Not Specified) 		abnormal atrial thrombosis J:146424
Tg(PF4-tTA/VP16)42Kra/0
Tg(tetO-Aurkb,lacZ)41Kra/0
(FVB/NJ-Tg(tetO-Aurkb,lacZ)41Kra Tg(PF4-tTA/VP16)42Kra) 		abnormal platelet physiology J:104239
Tg(PML-RARA)556Kog/?
(involves: FVB/N) 		abnormal blood coagulation J:39327
abnormal lung thrombosis J:39327
Tg(SFTPC-Tnf)2Pva/0
(involves: C57BL/6 * DBA/2) 		abnormal blood coagulation J:28120
Tg(Tek-cre)1Ywa/0
Thbdtm2Rdr/Thbdtm2Wlr
(involves: 129S2/SvPas * C57BL/6 * SJL) 		abnormal blood coagulation J:71269
abnormal placental thrombosis J:71269
abnormal thrombosis J:71269
Tg(Tek-Procr)1Cte/0
(B6.FVB-Tg(Tek-Procr)1Cte) 		abnormal blood coagulation J:119637
abnormal platelet physiology J:119637
Tg(Tek-tTA)1Rwng/0
Tg(tetO-Notch4*)1Rwng/0
(involves: FVB/N) 		abnormal thrombosis J:139943
Tg(WTbeta2)4Wjk/?
(Not Specified) 		abnormal atrial thrombosis J:128583
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv) 		abnormal atrial thrombosis J:50848
Thbdtm1Wlr/Thbdtm1Wlr
(B6.129S2-Thbdtm1Wlr) 		abnormal blood coagulation J:111502
increased susceptibility to induced thrombosis J:111502
Thbdtm1Wlr/Thbdtm2Rdr
(involves: 129S2/SvPas * C57BL/6) 		abnormal blood coagulation J:111502
abnormal lung thrombosis J:47676
increased susceptibility to induced thrombosis J:111502
Thbs1tm1Hyn/Thbs1tm1Hyn
Thbs2tm1Bst/Thbs2tm1Bst
(involves: 129T2/SvEms * 129X1/SvJ) 		increased bleeding time J:78876
Thbs2tm1Bst/Thbs2tm1Bst
(either: (involves: 129S4/SvJae * 129X1/SvJ) or (involves: 129X1/SvJ)) 		increased bleeding time J:45509
Thop1Gt(CSG163)Byg/Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg) 		increased bleeding time J:290567
Tln1tm1.1Bpet/Tln1tm4.1Crit
Tg(Pf4-icre)Q3Rsko/0
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal platelet physiology J:177971
reduced thrombolysis J:177971
Tln1tm4.1Crit/Tln1tm4.1Crit
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal platelet activation J:129708
abnormal thrombosis J:129708
increased bleeding time J:129708
Tln1tm4.1Crit/Tln1tm4.1Crit
Tg(Pf4-icre)Q3Rsko/?
(involves: 129P2/OlaHsd) 		abnormal platelet activation J:129707
abnormal thrombosis J:129707
increased bleeding time J:129707
Tln1tm4.1Crit/Tln1tm4.1Crit
Tg(Pf4-icre)Q3Rsko/0
(involves: 129P2/OlaHsd * C57BL/6) 		reduced thrombolysis J:177971
Tmem163em1Lwbch/Tmem163em1Lwbch
(C57BL/6J-Tmem163em1Lwbch) 		abnormal platelet physiology J:323340
decreased platelet aggregation J:323340
increased bleeding time J:323340
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal thrombosis J:117987
Treml1tm1Mcvic/Treml1tm1Mcvic
(C57BL/6-Treml1tm1Mcvic) 		decreased platelet aggregation J:150578
increased bleeding time J:150578
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac) 		abnormal atrial thrombosis J:220965
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd) 		abnormal atrial thrombosis J:92264
Trim55tm1Slbt/Trim55tm1Slbt
Trim63tm1Slbt/Trim63tm1Slbt
(involves: 129 * C57BL/6) 		abnormal cardiac thrombosis J:130921
Tspan18tm1Lex/Tspan18tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		abnormal hemostasis J:295079
decreased susceptibility to induced thrombosis J:295079
Tubb1tm1Shiv/Tubb1tm1Shiv
(involves: 129/Sv * BALB/c) 		increased bleeding time J:94498
Tubb1tm1Shiv/Tubb1tm1Shiv
(Not Specified) 		abnormal platelet physiology J:95293
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J) 		abnormal glomerular capillary thrombosis J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J) 		abnormal glomerular capillary thrombosis J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv) 		abnormal glomerular capillary thrombosis J:309768
Txniptm1Jjy/Txniptm1Jjy
(involves: C57BL/6 * CBA) 		increased bleeding time J:104563
increased partial thromboplastin time J:104563
increased prothrombin time J:104563
Tyrp1b-J/Tyrp1b-J
(C57BL/6J-Tyrp1b-J/J) 		decreased bleeding time J:7327
Tyrp1B-lt/Tyrp1B-lt
(involves: C57BL/6J) 		increased bleeding time J:7327
Unc13dtm1(KOMP)Vlcg/Unc13dtm1(KOMP)Vlcg
(involves: C57BL/6NTac) 		abnormal platelet dense granule physiology J:231217
decreased platelet aggregation J:231217
impaired blood coagulation J:231217
increased bleeding time J:231217
urehr1/urehr1
(C3HeB/FeJ-urehr1) 		abnormal glomerular capillary thrombosis J:121470
Vamp3tm1Jpes/Vamp3tm1Jpes
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal platelet physiology J:121010
Vamp8tm1Hong/Vamp8tm1Hong
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal platelet activation J:121010
abnormal platelet physiology J:121010
Vasptm1Mzim/Vasptm1Mzim
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal platelet activation J:56356
Vasptm1Ref/Vasptm1Ref
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal platelet physiology J:51905
increased platelet aggregation J:51905
Vkorc1L128S/Vkorc1L128S
(involves: wild) 		abnormal blood coagulation J:101681
Vkorc1tm1.1Jobg/Vkorc1tm1.1Jobg
(involves: 129S4/SvJae * BALB/cJ * C57BL/6) 		abnormal blood coagulation J:207884
Vkorc1Y139C/Vkorc1Y139C
(involves: Swiss outbred * wild) 		abnormal blood coagulation J:101681
Vps33abf/Vps33abf
(C57BL/6J-Vps33abf) 		abnormal blood coagulation J:88018
abnormal platelet physiology J:88018
decreased platelet aggregation J:88018
increased bleeding time J:7327
Vps33btm1.1Arte/Vps33btm1.1Arte
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J) 		decreased platelet aggregation J:222766
increased bleeding time J:222766
Vtntm1Dgi/Vtntm1Dgi
(B6.129S2-Vtntm1Dgi) 		abnormal blood coagulation J:134443
abnormal platelet aggregation J:134443
Vwftm1.1Diac/Vwftm1.1Diac
(Not Specified) 		abnormal platelet activation J:181672
impaired blood coagulation J:220792
increased bleeding time J:220792, J:181672
Vwftm1.1Geno/Vwf+
(involves: C57BL/6) 		abnormal platelet aggregation J:250145
abnormal platelet physiology J:250145
decreased platelet aggregation J:250145
increased bleeding time J:250145
Vwftm1.1Geno/Vwftm1.1Geno
(involves: C57BL/6) 		abnormal platelet aggregation J:250145
abnormal platelet physiology J:250145
decreased platelet aggregation J:250145
decreased susceptibility to induced thrombosis J:250145
increased bleeding time J:250145
Vwftm1.1Vhf/Vwf+
(involves: C57BL/6J * C57BL/6N) 		abnormal blood coagulation J:295694
abnormal platelet physiology J:295694
decreased susceptibility to induced thrombosis J:295694
increased bleeding time J:295694
Vwftm1.1Vhf/Vwftm1.1Vhf
(involves: C57BL/6J * C57BL/6N) 		abnormal blood coagulation J:295694
abnormal platelet physiology J:295694
decreased susceptibility to induced thrombosis J:295694
increased bleeding time J:295694
Vwftm1Wgr/Vwf+
(involves: 129S2/SvPas * C57BL/6J) 		abnormal blood coagulation J:49083
Vwftm1Wgr/Vwftm1Wgr
(involves: 129S2/SvPas * C57BL/6J) 		abnormal blood coagulation J:49083
abnormal platelet physiology J:49083
decreased susceptibility to induced thrombosis J:63750
increased bleeding time J:49083
increased partial thromboplastin time J:49083
Vwftm1Wgr/Vwftm1Wgr
(B6.129S2-Vwftm1Wgr) 		decreased susceptibility to induced thrombosis J:133469
Vwftm2.1Diac/Vwftm2.1Diac
(Not Specified) 		impaired blood coagulation J:220792
increased bleeding time J:220792
Vwftm3.1(VWF)Diac/Vwftm3.1(VWF)Diac
(Not Specified) 		impaired blood coagulation J:220792
increased bleeding time J:220792
Wdr1rede/Wdr1rede
(C57BL/6-Wdr1rede) 		increased bleeding time J:134092
Wrntm1Led/Wrntm1Led
(involves: 129S6/SvEvTac * Black Swiss) 		abnormal thrombosis J:106446
Wwtr1tm1.1Eno/Wwtr1tm1.1Eno
Yap1tm1.1Eno/Yap1+
Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N) 		abnormal atrial thrombosis J:200670
Yap1tm1.1Eno/Yap1tm1.1Eno
Tg(Myh6-cre)2182Mds/0
(involves: 129S/SvEv * FVB/N) 		abnormal atrial thrombosis J:200670
Yod1em1Smoc/Yod1em1Smoc
(C57BL/6JSmoc-Yod1em1Smoc/Smoc) 		abnormal blood coagulation J:350806
increased partial thromboplastin time J:350806
increased susceptibility to induced thrombosis J:350806
Zfp385atm1Ber/Zfp385atm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal blood coagulation J:93829
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory